
Chinese General Practice ›› 2021, Vol. 24 ›› Issue (26): 3349-3358.DOI: 10.12114/j.issn.1007-9572.2021.01.206
Special Issue: 肿瘤最新文章合辑; 乳腺癌最新文章合辑; 女性健康最新文章合辑
• Monographic Research • Previous Articles Next Articles
Published:2021-09-15
Online:2021-09-15
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2021.01.206
| [1]江泽飞,李健斌. 乳腺癌诊疗指南和临床实践历程[J]. 中华外科杂志,2020,58(2):85-90. DOI:10.3760/cma.j.issn.0529-5815.2020.02.002. JIANG Z F,LI J B. Development of guidelines and clinical practice for breast cancer[J]. Chinese Journal of Surgery,2020,58(2):85-90. DOI:10.3760/cma.j.issn.0529-5815.2020.02.002. [2]KIEFER J,KOULAXOUZIDIS G,STARK G B,et al. An integrative therapeutic concept for surgical treatment of severe cases of lymphedema of the lower extremity[J]. Obes Surg,2016,26(7):1436-1442. DOI:10.1007/s11695-015-1982-2. [3]TURFE Z,PETTINGA J,LEDUC O,et al. Chemotherapy port related lymphedema after axillary lymph node dissection[J]. Breast,2016,28:145-147. DOI:10.1016/j.breast.2016.05.008. [4]VETTO J T. Lymphedema after breast cancer treatment-not just the surgeon's fault[J]. JAMA Surg,2019,154(9):810. DOI:10.1001/jamasurg.2019.1743. [5]谢玉环,郭旗,刘风华,等. 乳腺癌相关上肢淋巴水肿危险因素荟萃分析[J]. 中华放射肿瘤学杂志,2014,23(2):93-98. DOI:10.3760/cma.j.issn.1004-4221.2014.02.003. XIE Y H,GUO Q,LIU F H,et al. Risk factors for breast cancer-related upper extremity lymphedema:a meta-analysis[J]. Chinese Journal of Radiation Oncology,2014,23(2):93-98. DOI:10.3760/cma.j.issn.1004-4221.2014.02.003. [6]ZHU Y Q,XIE Y H,LIU F H,et al. Systemic analysis on risk factors for breast cancer related lymphedema[J]. Asian Pac J Cancer Prev,2014,15(16):6535-6541. DOI:10.7314/apjcp.2014.15.16.6535. [7]DISIPIO T,RYE S,NEWMAN B,et al. Incidence of unilateral arm lymphoedema after breast cancer:a systematic review and meta-analysis[J]. Lancet Oncol,2013,14(6):500-515. DOI:10.1016/S1470-2045(13)70076-7. [8]陈波,贾实,张文海,等. 乳腺癌术后上肢淋巴水肿的危险因素分析[J]. 中国医科大学学报,2012,41(7):637-641. DOI:10.3969/j.issn.0258-4646.2012.07.017. CHEN B,JIA S,ZHANG W H,et al. Analysis on risk factors for arm lymphedema following breast cancer surgery[J]. Journal of China Medical University,2012,41(7):637-641. DOI:10.3969/j.issn.0258-4646.2012.07.017. [9]胡艳,刘晓倩,黄瑾,等.乳腺癌相关淋巴水肿发病情况及危险因素回顾队列研究[J]. 中华放射肿瘤学杂志,2016,25(10):1083-1087. DOI:10.3760/cma.j.issn.1004-4221.2016.10.013. HU Y,LIU X Q,HUANG J,et al. Incidence and risk factors for breast cancer-related lymphedema:a retrospective cohort study[J]. Chinese Journal of Radiation Oncology,2016,25(10):1083-1087. DOI:10.3760/cma.j.issn.1004-4221.2016.10.013. [10]闫宇,周灿. 中美两国女性乳腺癌临床病理特征及治疗的对比研究[J]. 现代肿瘤医学,2019,27(8):1344-1351. DOI:10.3969/j.issn.1672-4992.2019.08.014. YAN Y,ZHOU C. A comparative study of clinic-pathological features and treatment of female breast cancer in China and USA[J]. Journal of Modern Oncology,2019,27(8):1344-1351. DOI:10.3969/j.issn.1672-4992.2019.08.014. [11]左婷婷. 种族间乳腺癌生存率的差异:调整肿瘤特征、社会人口特征和治疗因素的效应[J]. 中华预防医学杂志,2017,51(6):500. DOI:10.3760/cma.j.issn.0253-9624.2017.06.012. https://d.wanfangdata.com.cn/periodical/ChlQZXJpb2RpY2FsQ0hJTmV3UzIwMjEwNTIxEg96aHlmeXgyMDE3MDYwMTIaCHQzcG43emxs. [12]WELLS G,SHEA B,O'CONNELL J. The Newcastle-Ottawa Scale(NOS)for assessing the quality of non-randomised studies in Meta-analyses[J]. Appl Eng Agric,2014,18(6):727-734. [13]陈小燕. 乳腺癌术后上肢淋巴水肿的危险因素分析[J]. 世界最新医学信息文摘,2018,18(A0):9,206. DOI:10.19613/j.cnki.1671-3141.2018.100.005. CHEN X Y. Analysis of risk factors for upper limb lymphedema after breast cancer operation[J]. World Latest Medicine Information,2018,18(A0):9,206. DOI:10.19613/j.cnki.1671-3141.2018.100.005. [14]陈澎涛. 乳腺癌患者术后上肢淋巴水肿的危险因素分析[J]. 中国医药科学,2016,6(18):147-149. DOI:10.3969/j.issn.2095-0616.2016.18.045. CHEN P T. Risk factor analysis for upper limb lymphedema after radical mastectomy[J]. China Medicine and Pharmacy,2016,6(18):147-149. DOI:10.3969/j.issn.2095-0616.2016.18.045. [15]丰锦春,吴涛,吐鲁洪?沙列尔,等. 乳腺癌腋窝淋巴结清扫术后上肢淋巴水肿的危险因素分析[J]. 现代诊断与治疗,2018,29(20):3250-3252. DOI:10.3969/j.issn.1001-8174.2018.20.030. https://d.wanfangdata.com.cn/periodical/ChlQZXJpb2RpY2FsQ0hJTmV3UzIwMjEwNTIxEhB4ZHpkeXpsMjAxODIwMDMwGghlMWtuMjg5eA%3D%3D. [16]黄关立,吕世旭,郝儒田,等. 乳腺癌病人上肢淋巴水肿的多因素分析[J]. 外科理论与实践,2011,16(1):39-41. DOI:10.16139/j.1007-9610.2011.01.017. HUANG G L,LYU S X,HAO R T,et al. A multiple variable analysis about the risk factors of breast cancer related arm lymphedema[J]. Journal of Surgery Concepts & Practice,2011,16(1):39-41. DOI:10.16139/j.1007-9610.2011.01.017. [17]黄婧慧,黄枫,朱佩,等. 女性乳腺癌术后上肢淋巴水肿危险因素调查分析[J]. 康复学报,2019,29(5):5-9. DOI:10.3724/SP.J.1329.2019.05005. HUANG J H,HUANG F,ZHU P,et al. Risk factors of upper limb lymphedema after breast cancer surgery in women[J]. Rehabilitation Medicine,2019,29(5):5-9. DOI:10.3724/SP.J.1329.2019.05005. [18]刘风华,胡艳,沈培佩,等. 乳腺癌相关淋巴水肿发病情况及危险因素前瞻性队列研究[J]. 中华放射肿瘤学杂志,2016,25(6):593-597. DOI:10.3760/cma.j.issn.1004-4221.2016.06.011. LIU F H,HU Y,SHEN P P,et al. Lymphedema after surgical treatment for breast cancer:a 2-year follow-up study of incidence and risk factors[J]. Chinese Journal of Radiation Oncology,2016,25(6):593-597. DOI:10.3760/cma.j.issn.1004-4221.2016.06.011. [19]刘军,王伟,陈成玲. 乳腺癌术后上肢淋巴水肿的危险因素分析[J]. 肿瘤学杂志,2018,24(1):70-73. DOI:10.11735/j.issn.1671-170X.2018.01.B016. LIU J,WANG W,CHEN C L. Risk factors of postoperative upper limb lymph edema in patients with breast cancer[J]. Journal of Chinese Oncology,2018,24(1):70-73. DOI:10.11735/j.issn.1671-170X.2018.01.B016. [20]刘祥伟,曲延玉,陈德滇. 乳腺癌患者术后并发淋巴水肿的危险因素分析[J]. 国际肿瘤学杂志,2018,45(5):262-268. DOI:10.3760/cma.j.issn.1673-422X.2018.05.002. LIU X W,QU Y Y,CHEN D D. Risk factors for postoperative lymphedema in breast cancer patients[J]. Journal of International Oncology,2018,45(5):262-268. DOI:10.3760/cma.j.issn.1673-422X.2018.05.002. [21]陆永奎,陈闯,张作军,等. 乳腺癌术后上肢淋巴水肿及其相关危险因素的分析[J]. 临床医药实践,2006,15(6):435-437. DOI:10.3969/j.issn.1671-8631.2006.06.017. https://d.wanfangdata.com.cn/periodical/sxlcyy200606017. [22]王季,张意辉,张丽娟,等. 体重指数及体重波动对乳腺癌患者上肢淋巴水肿的影响[J]. 中国康复医学杂志,2020,35(2):182-185. DOI:10.3969/j.issn.1001-1242.2020.02.011. https://d.wanfangdata.com.cn/periodical/ChlQZXJpb2RpY2FsQ0hJTmV3UzIwMjEwNTIxEhF6Z2tmeXh6ejIwMjAwMjAxMRoIaHk2NDhpeTc%3D. [23]王洪波,郑静.乳腺癌术后患侧上肢淋巴水肿防治探讨[J]. 现代仪器与医疗,2017,23(2):41-43. DOI:10.11876/mimt201704017. https://d.wanfangdata.com.cn/periodical/xdyq201702017. [24]杨杰,高明. 乳腺癌术后上肢淋巴水肿危险因素的临床观察[J]. 浙江创伤外科,2015,(1):114-116. DOI:10.3969/j.issn.1009-7147.2015.01.057. https://d.wanfangdata.com.cn/periodical/ChlQZXJpb2RpY2FsQ0hJTmV3UzIwMjEwNTIxEhB6amNzd2syMDE1MDEwMDU4Ggg5Y3d2YTliYQ%3D%3D. [25]杨潜,苏东玮,施俊义,等. 乳腺癌腋窝淋巴结清扫术后上肢淋巴水肿的危险因素分析[J]. 现代生物医学进展,2009,9(16):3081-3085. YANG Q,SU D W,SHI J Y,et al. Analysis of the risk factors of the arm lymphedema following axillary lymph node dissection for breast cancer[J]. Progress in Modern Biomedicine,2009,9(16):3081-3085. [26]杨庄青,邹天宁,陈德滇,等. 乳腺癌腋窝淋巴结清扫术后上肢淋巴水肿的危险因素分析[J]. 现代生物医学进展,2012,12(35):6909-6911,6916. DOI:10.13241/j.cnki.pmb.2012.35.042. YANG Z Q,ZOU T N,CHEN D D,et al. Analysis of the risk factors of arm lymphedema following axillary lymph node dissection with breast cancer[J]. Progress in Modern Biomedicine,2012,12(35):6909-6911,6916. DOI:10.13241/j.cnki.pmb.2012.35.042. [27]张辉. 乳腺癌改良根治术后上肢淋巴水肿的危险因素分析[D]. 温州:温州医科大学,2017. ZHANG H. Risk factors of upper extremity lymphedema after modified radical mastectomy for breast cancer[D]. Wenzhou:Wenzhou Medical University,2017. [28]张顺康,郑磊贞,陈刚,等. 乳腺癌新辅助化疗患者上肢淋巴水肿的危险因素分析[J]. 中国癌症杂志,2017,27(10):815-821. DOI:10.19401/j.cnki.1007-3639.2017.10.009. ZHANG S K,ZHENG L Z,CHEN G,et al. Anylasis of risk factors for arm lymphedema in breast cancer patients treated with neoadjuvant chemotherapy[J]. China Oncology,2017,27(10):815-821. DOI:10.19401/j.cnki.1007-3639.2017.10.009. [29]唐小乔,苏磊,桑剑锋. 乳腺癌改良根治术后上肢淋巴水肿与腋窝淋巴结阳性率的相关性分析[J]. 中华普外科手术学杂志(电子版),2020,14(1):74-77. DOI:10.3877/cma.j.issn.1674-3946.2020.01.022. (下转第3376页) TANG X Q,SU L,SANG J F. Correlation analysis of upper extremity lymphedema and axillary lymph node positive rate after modified radical mastectomy for breast cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition),2020,14(1):74-77. DOI:10.3877/cma.j.issn.1674-3946.2020.01.022. [30]郑建伟,蔡淑艳,宋慧敏,等. 乳腺癌患者术后上肢淋巴水肿的危险因素分析[J]. 中华乳腺病杂志(电子版),2015,9(6):363-366. DOI:10.3877/cma.j.issn.1674-0807.2015.06.003. ZHANG J W,CAI S Y,SONG H M,et al. Risk factor analysis for upper extremity lymphedema after breast cancer surgery[J]. Chinese Journal of Breast Disease(Electronic Edition),2015,9(6):363-366. DOI:10.3877/cma.j.issn.1674-0807.2015.06.003. [31]任阳光. 不同术式在乳腺癌术后上肢淋巴水肿相关影响因素中的作用[D]. 郑州:郑州大学,2016. REN Y G. The role of different surgical methods in upper extremity lymphedema-related factors after breast cancer surgery[D]. Zhengzhou:Zhengzhou University,2016. [32]吴师容,文成玉,赵文瑶,等. 放疗后上肢乳腺癌相关淋巴水肿的危险因素分析[J]. 解放军医药杂志,2018,30(3):52-54. DOI:10.3969/j.issn.2095-140X.2018.03.013. WU S R,WEN C Y,ZHAO W Y,et al. Analysis of risk factors of upper limb breast cancer related lymphedema after radiotherapy[J]. Medical and Pharmaceutical Journal of Chinese People's Liberation Army,2018,30(3):52-54. DOI:10.3969/j.issn.2095-140X.2018.03.013. [33]张顺康,孙丽云,陈刚. 乳腺癌改良根治术后放疗患者上肢淋巴水肿与腋淋巴结手术结果的相关性分析[J]. 中国癌症杂志,2018,28(1):55-61. DOI:10.19401/j.cnki.1007-3639.2018.01.008. ZHANG S K,SUN L Y,CHEN G. Correlation analysis of upper limb lymphedema and the outcome of axillary lymph node surgery in breast cancer patients treated with postmastectomy radiation therapy[J]. China Oncology,2018,28(1):55-61. DOI:10.19401/j.cnki.1007-3639.2018.01.008. [34]LU S R,HONG R B,CHOU W,et al. Role of physiotherapy and patient education in lymphedema control following breast cancer surgery[J]. Ther Clin Risk Manag,2015,11(10):319-327. DOI:10.2147/TCRM.S77669. [35]HUANG H P,ZHOU J R,QING Z. Risk factors associated with lymphedema among postmenopausal breast cancer survivors after radical mastectomy and axillary dissection in China[J]. Breast Care(Basel),2012,7(6):461-464. DOI:10.1159/000345459. [36]LI X P,HUANG H,LIN Q M,et al. Validation of a breast cancer nomogram to predict lymphedema in a Chinese population[J]. J Surg Res,2017,210:132-138. DOI:10.1016/j.jss.2016.11.009. [37]MAK S S,YEO W,LEE Y M,et al. Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong[J]. Nurs Res,2008,57(6):416-425. DOI:10.1097/NNR.0b013e31818c3de2. [38]PENN I W,CHANG Y C,CHUANG E,et al. Risk factors and prediction model for persistent breast-cancer-related lymphedema:a 5-year cohort study[J]. Support Care Cancer,2019,27(3):991-1000. DOI:10.1007/s00520-018-4388-6. [39]ZHANG X P,HE X M,TANG B B,et al. Risk factors of lymphedema on affected side of upper limb after breast cancer surgery——report from a single center of China[J]. Int J Clin Exp Med,2017,10(1):1592-1601. DOI:1940-5901/IJCEM0040612. [40]WANG L,LI H P,LIU A N,et al. A scoring system to predict arm lymphedema risk for individual Chinese breast cancer patients[J]. Breast Care(Basel),2016,11(1):52-56. DOI:10.1159/000443491. [41]ZOU L,LIU F H,SHEN P P,et al. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation:a 2-year follow-up prospective cohort study[J]. Breast Cancer,2018,25(3):309-314. DOI:10.1007/s12282-018-0830-3. [42]贾杰. 规范乳腺癌术后上肢淋巴水肿的诊治流程[J]. 中国康复医学杂志,2018,33(4):375-378. DOI:10.3969/j.issn.1001-1242.2018.04.001. https://d.wanfangdata.com.cn/periodical/ChlQZXJpb2RpY2FsQ0hJTmV3UzIwMjEwNTIxEhF6Z2tmeXh6ejIwMTgwNDAwMRoIbmU0NHJ4eDE%3D. [43]孙章秀. 青年乳腺癌的研究进展[J]. 海南医学,2020,31(12):1610-1613. DOI:10.3969/j.issn.1003-6350.2020.12.033. SUN Z X. Advance on young breast cancer[J]. Hainan Medical Journal,2020,31(12):1610-1613. DOI:10.3969/j.issn.1003-6350.2020.12.033. [44]PETREK J A,SENIE R T,PETERS M,et al. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis[J]. Cancer,2001,92(6):1368-1377. DOI:10.1002/1097-0142(20010915)92:6<1368:aid-cncr1459>3.0.co;2-9. [45]CLARK B,SITZIA J,HARLOW W. Incidence and risk of arm oedema following treatment for breast cancer:a three-year follow-up study[J]. QJM,2005,98(5):343-348. DOI:10.1093/qjmed/hci053. [46]刘晓溪,王世宣. 乳腺癌术后上肢淋巴水肿的发生因素分析与护理[J]. 护士进修杂志,2016,31(8):715-717. DOI:10.16821/j.cnki.hsjx.2016.08.014. https://d.wanfangdata.com.cn/periodical/hsjxzz201608016. [47]国家卫生健康委员会疾病预防控制局,国家心血管病中心,中国医学科学院阜外医院,等. 中国高血压健康管理规范(2019)[J]. 中华心血管病杂志,2020,48(1):10-46. DOI:10.3760/cma.j.issn.0253-3758.2020.01.004. Bureau of Disease Control and Prevention,National Health Commission,National Center for Cardiovascular Diseases,Fuwai Hospital,Chinese Academy of Medical Sciences,et al. National guideline for hypertension management in China(2019)[J]. Chinese Journal of Cardiology,2020,48(1):10-46. DOI:10.3760/cma.j.issn.0253-3758.2020.01.004. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||